Policy Watch: 26 Regulatory Updates — March 08, 2026
The marijuana rescheduling proposal is a key focus in the March 2026 regulatory updates. This change could impact cannabis clinical practice and research access. Marijuana rescheduling remains central to evolving federal cannabis policy.
Daily Digest: Last 38 Hours: Cannabinoids, Liver Disease, and the Adolescent Brain — March 08, 2026
This digest highlights cannabinoid drug delivery breakthroughs alongside key findings on liver disease and adolescent brain health. Advances in delivery technology improve cannabinoid bioavailability and therapeutic potential. Clinicians should consider…
Regulatory Digest: Marijuana Rescheduling and Clinical Research
Marijuana rescheduling clinical research is a pivotal topic in 2026 regulatory updates. This shift could enable expanded clinical trials and evidence-based cannabis therapeutics. Understanding these changes is essential for clinicians and researchers…
In the Mix: 20 More Articles — March 08, 2026
This summary covers cannabis pediatric exposure toxicity reported in recent articles. Acute cannabinoid toxicity in children remains a critical clinical concern. The focus is on ingestion risks, symptoms, and management.
Endocannabinoid System Research: Cannabis PTSD Meta-Analysis
This cannabis PTSD meta-analysis examines trauma-focused treatment outcomes in patients with co-occurring substance use disorders. Findings show trauma-focused therapies remain effective regardless of cannabis use. Clinicians should consider these…
New study reveals surprising benefit of GLP-1s beyond weight loss
A recent study highlights the potential of GLP-1 addiction risk reduction in lowering vulnerability to multiple substances. This research suggests GLP-1 receptor agonists may influence reward pathways independently of weight loss. Clinicians should…
Youth and Cannabis: Understanding the Risks to the Adolescent Brain
Cannabis use adolescent brain risks are a growing concern as legalization expands. Clinicians face challenges counseling youth due to variable product potency and incomplete data. Understanding these risks is crucial for adolescent health and safety.
Smoking Cannabis May Reduce Alcohol Cravings, New Study Finds – Food & Wine
Cannabis alcohol cravings research suggests cannabis use may reduce alcohol cravings in some patients. This emerging evidence highlights potential harm reduction strategies for alcohol use disorder. Clinicians should carefully assess risks and benefits…
Study: Cannabis Use Among Older Adults Does Not Accelerate Mental Decline
This study on cannabis use and cognitive safety in older adults found no evidence of accelerated mental decline. The findings challenge previous assumptions about cannabis and aging cognition. This evidence supports individualized clinical assessments…
Study: Adolescent Cannabis Use Doubles Psychotic and Bipolar Disorder Risk
Adolescent cannabis psychotic risk is significantly elevated, doubling the likelihood of psychotic and bipolar disorders. This study highlights the critical neurodevelopmental vulnerability during teenage years. Clinicians should prioritize screening and…
